Skip to content

13F-HR filed by Prescott General Partners LLC

Prescott General Partners LLC filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-15, with 12 holding rows worth $1,456,686,000.

Accession
0001104659-22-091325
Filed
2022-08-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2022

A holdings report, 12 entries on the cover page, a total value of $1,456,686,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,456,686,000 with VALUE read as thousands by filing date, 13F file number 028-14951. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CREDIT ACCEP CORP MICH225310101COM1,632,368$772,779,000thousands by filing date
WORLD ACCEP CORPORATION981419104COM2,037,495$228,688,000thousands by filing date
WAYFAIR INC94419L101CL A3,823,239$166,540,000thousands by filing date
CIMPRESS PLCG2143T103SHS EURO3,906,492$151,963,000thousands by filing date
YELP INC CL A985817105Stock2,909,751$80,804,000thousands by filing date
GLOBAL INDUSTRIAL COMPANY COM37892E102Stock1,279,677$43,215,000thousands by filing date
VAPOTHERM INC922107107COM2,557,243$6,470,000thousands by filing date
LINEAGE CELL THERAPEUTICS IN53566P109COMMON STOCK1,851,851$2,926,000thousands by filing date
HUMACYTE INC44486Q103COM568,246$1,824,000thousands by filing date
SANA BIOTECHNOLOGY INC799566104COM122,097$785,000thousands by filing date
ALTIMMUNE INC02155H200COM NEW50,000$585,000thousands by filing date
AGEX THERAPEUTICS INC00848H108COM185,185$107,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-22-091325this filing2022-08-15acceptance time not in the bulk data set